LumiraDx Investor Presentation Deck

Key Targets and Workflow ● 98% sensitivity • No culture confirmation Results in 8 minutes, with early call out starting 3 minutes Performance Feasibility Fluorescence (R) 70000 60000 50000 40000 30000 20000 10000 0 0 5 D1 (1:20) Group A Strep 10 Strep A Molecular Program Demonstrates Feasibility to Achieve Target Sensitivity 15 20 Cycles 25 30 lumiraDx™ 35 40 Fluorescence (R) 70000 60000 50000 40000 30000 20000 10000 0 0 D2 (1:200) 5 Group A Strep 10 15 20 Cycles 25 30 35 40 Fluorescence (R) 70000 60000 50000 40000 30000 20000 10000 0 0 Sample Collection & Lysis D3 (1:2000) 5 10 Group A Strep 15 20 Cycles 25 30 35 40 Fluorescence (R) 70000 60000 50000 40000 30000 20000 10000 0 5 Insert Strip & Add Sample D4 (1:20000) Group A Strep 10 Copyright © 2023 LumiraDx Ltd. All Rights Reserved, Worldwide. → 9 → 15 20 Cycles 25 30 35 40 Dilution D1 (1:10¹) D2 (1:10²) D3 (1:10³) D4 (1:104) D5 (1:105) D6 (1:106) D7 (1:107) Amplification LMDX qSTAR 8/8 8/8 8/8 8/8 0/8 0/8 0/8 On market POC MDX 3/3 3/3 3/3 2/3 0/3 0/3 0/3

View entire presentation